ATE74007T1 - Immunoverstaerker und verfahren zu ihrer herstellung. - Google Patents

Immunoverstaerker und verfahren zu ihrer herstellung.

Info

Publication number
ATE74007T1
ATE74007T1 AT85110104T AT85110104T ATE74007T1 AT E74007 T1 ATE74007 T1 AT E74007T1 AT 85110104 T AT85110104 T AT 85110104T AT 85110104 T AT85110104 T AT 85110104T AT E74007 T1 ATE74007 T1 AT E74007T1
Authority
AT
Austria
Prior art keywords
processes
production
immune enhancers
materials
immune
Prior art date
Application number
AT85110104T
Other languages
English (en)
Inventor
Arthur A Gottlieb
Original Assignee
Arthur A Gottlieb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arthur A Gottlieb filed Critical Arthur A Gottlieb
Application granted granted Critical
Publication of ATE74007T1 publication Critical patent/ATE74007T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Steroid Compounds (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Lining Or Joining Of Plastics Or The Like (AREA)
  • Processing Of Solid Wastes (AREA)
  • Medicines Containing Plant Substances (AREA)
AT85110104T 1984-08-24 1985-08-12 Immunoverstaerker und verfahren zu ihrer herstellung. ATE74007T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/643,724 US4616079A (en) 1984-08-24 1984-08-24 Immunoamplifiers and processes for the extraction thereof
EP85110104A EP0173889B1 (de) 1984-08-24 1985-08-12 Immunoverstärker und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE74007T1 true ATE74007T1 (de) 1992-04-15

Family

ID=24582025

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85110104T ATE74007T1 (de) 1984-08-24 1985-08-12 Immunoverstaerker und verfahren zu ihrer herstellung.

Country Status (4)

Country Link
US (1) US4616079A (de)
EP (1) EP0173889B1 (de)
AT (1) ATE74007T1 (de)
DE (1) DE3585713D1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699898A (en) * 1985-12-26 1987-10-13 Imreg, Inc. Tripeptides affecting immune response
CA1286989C (en) 1985-12-26 1991-07-30 A. Arthur Gottlieb Immunoamplifiers and related compositions
DE3782958D1 (de) * 1986-02-19 1993-01-21 Imreg Inc Verfahren und mittel zum pruefen eines immunsystems.
US4710380A (en) * 1986-04-04 1987-12-01 Imreg, Inc. Treatment of autoimmune disorders with immunoamplifiers
EP0247538A3 (de) * 1986-05-28 1989-08-30 Imreg, Inc. Immunosuppressivum und Verfahren zu seiner Extraktion
PT87133B (pt) * 1987-04-02 1992-07-31 Amrad Corp Ltd Metodo de purificacao do factor inibidor da leucemia (lif) e de composicoes farmaceuticas contendo polipeptidos com actividade do lif
US5013546A (en) * 1988-08-23 1991-05-07 Imreg, Inc. Methods for modulating antibody production in treating patients with AIDS, ARC and other diseases
WO1992000087A1 (en) * 1990-07-02 1992-01-09 National Jewish Center For Immunology And Respiratory Medicine Process for obtaining pure peptide transfer factor, transfer factor thus obtained and uses thereof
WO1992000093A1 (en) * 1990-07-02 1992-01-09 National Jewish Center For Immunology And Respiratory Medicine Transfer factor and methods of use
US5883224A (en) * 1996-04-19 1999-03-16 Cytokine Sciences, Inc. Characterization of transfer factors and methods of use
US7632818B2 (en) * 2003-03-20 2009-12-15 Gottlieb Marise S Method for treating conditions associated with the Metabolic Syndrome (Syndrome X)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991182A (en) * 1971-10-19 1976-11-09 The Regents Of The University Of California Transfer factor
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
NO156516C (no) * 1980-05-14 1987-10-07 A Arthur Gottlieb Fremgangsmaate for fremstilling av modulatorer for immunsystemet.
US4435384A (en) * 1982-04-30 1984-03-06 Viragen, Inc. Transfer factor composition and skin treatment
US4468379A (en) * 1982-05-06 1984-08-28 Endeavor Corp. Leukocyte extracts for affecting the immune system

Also Published As

Publication number Publication date
EP0173889A2 (de) 1986-03-12
US4616079A (en) 1986-10-07
DE3585713D1 (de) 1992-04-30
EP0173889B1 (de) 1992-03-25
EP0173889A3 (en) 1987-02-04

Similar Documents

Publication Publication Date Title
AT305288B (de) Verfahren zur Herstellung neuer 1-substituierter Tetrahydro-2-(1H)pyrimidone
ATE74007T1 (de) Immunoverstaerker und verfahren zu ihrer herstellung.
NL7903400A (nl) Werkwijze voor de bereiding van alpha,beta-onverzadigde n-gesubstitueerde carbonzuuramiden.
DK232483D0 (da) Fremgangsmade til fremstilling af ws 6049-forbindelser
DK617386D0 (da) Fremgangsmaade til fremstilling af 2-keto-d-glucarsyre
JPS5386089A (en) Preparation of l-lysine by fermentation
JPS5386090A (en) Preparation of l-lysine by fermentation
AU4671685A (en) Separation process with recovery of proteins & fats from substances of animal origin, organic substances or refluent from working organic substances & plant to carry out the
JPS533586A (en) Preparation of l-amino acid by fermentation
ES477656A1 (es) Procedimiento para preparar acidos azulminicos modificados.
DK4586A (da) Fremgangsmaade til formering af begoniearter
ES8301956A1 (es) "procedimiento de aislar acido (+)-usnico".
JPS51123076A (en) The manufacturing process of field effect transistor
JPS51149328A (en) A hot-melt adhesive composition
JPS51123074A (en) Production process of fet
JPS527483A (en) Prparation of cholesterol esterase
AR223981A1 (es) Procedimiento para la fabricacion del compuesto m.139.603,mezcla y extracto de fermentacion y composicion
JPS5331682A (en) Preparation of pyrazinedicaroxyamide
JPS5212252A (en) Process for electrostatic flocking
JPS53130623A (en) Preparation of n-hydroxyalkyl-substituted phosphoroamidate
SU483455A1 (ru) Быстрорежуща сталь
JPS5213123A (en) Pipe joint
JPS51139680A (en) Method for purifing enzyme
JPS5278105A (en) Noise diminishing process in fluid machinery
JPS52128283A (en) Preparation of raw material of alcohol fermentation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee